Martin Dubravec
Allergy & Immunology · Cadillac, MINPI 1114013711
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 454 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AstraZeneca at 25.0% of the total.
Across 454 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$963
- Takeda Pharmaceuticals U.S.A., Inc.$626
- CSL Behring$563
- Novartis$434
- Genentech USA, Inc.$417
- plus $3K from 24 others
What the payments were for
- Food & beverage$7,26998%
- Education$1802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 105 | $1,861 |
| GSK | 86 | $963 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $626 |
| CSL Behring | 23 | $563 |
| Novartis | 24 | $434 |
| Genentech USA, Inc. | 30 | $417 |
| Sanofi | 17 | $338 |
| Blueprint Medicines Corporation | 11 | $307 |
| Regeneron Healthcare Solutions, Inc. | 11 | $257 |
| Electromed, Inc. | 17 | $223 |
| Amgen(2 entities) | 12 | $213 |
| Pharming Healthcare, Inc. | 11 | $170 |
| Teva Pharmaceuticals USA, Inc. | 18 | $162 |
| Kaleo, Inc. | 8 | $130 |
| Boehringer Ingelheim | 5 | $115 |
| Pfizer | 7 | $102 |
| Grifols USA, LLC | 4 | $95 |
| Sunovion Pharmaceuticals Inc. | 8 | $94 |
| Biocryst US Sales Co., LLC | 4 | $85 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $51 |
| Ionis Pharmaceuticals, Inc. | 1 | $40 |
| Biocryst Pharmaceuticals, Inc. | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Merck | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$7,449 in reported general payments places this provider in the 75th percentile of 119 allergy & immunology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 18 | $30,171 |
| Cromolyn Sodium | 56 | $26,097 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $24,458 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $8,870 |
| Epinephrine | 30 | $8,039 |
| DuleraMometasone/Formoterol | 12 | $7,323 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $5,955 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,538 |
| Hydroxychloroquine Sulfate | 136 | $3,838 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,901 |
| Montelukast Sodium | 201 | $2,620 |
| Zafirlukast | 22 | $2,511 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,477 |
| Ipratropium Bromide | 40 | $1,225 |
| Famotidine | 113 | $1,158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $963 | $28,99633 claims |
| Cycle Pharmaceuticals IncCromolyn Sodium | $17 | $26,09756 claims |
| MerckDulera | $13 | $7,32312 claims |
| AstraZenecaSymbicort | $1,861 | $2,90113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 119 allergy & immunology providers in Michigan.
Other allergy & immunology in Cadillac
- Steven StrykCanton$949K
- Hassan NasirWest Branch$736K
- Theodore KelbelGrand Rapids$695K
- Nicholas HartogGrand Rapids$575K
- Kathleen DassOak Park$446K
- Pulin PatelMount Clemens$431K
- Alan BaptistAnn Arbor$168K
- Mohsen NasirSaginaw$99K
- Abdul Husein BahrainwalaRoyal Oak$47K
- Jason ParisLivonia$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.